Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1300053
European Journal of Endocrinology, Vol 130, Issue 1, 53-59
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dehennin, L.
Right arrow Articles by Pérès, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dehennin, L.
Right arrow Articles by Pérès, G.

Urinary profile of androgen metabolites at different stages of pubertal development in a population of sporting male subjects

Louis Dehennin, Antonio Delgado and Gilbert Pérès

Dehennin L, Delgado A. Pérès G. Urinary profile of androgen metabolites at different stages of pubertal development in a population of sporting male subjects. Eur J Endocrinol 1994;130:53–9. ISSN 0804–4643

In this cross-sectional study on 140 subjects, several testosterone and epitestosterone metabolites have been analyzed by gas chromatography–mass spectrometry associated with stable isotope dilution, a technique requested for doping analysis in general, and detection of exogenous testosterone supply in particular. Urinary excretions of luteinizing hormone, testosterone and epitestosterone glucoronides and sulfates, as well as glucuronides of 5-androstene-3β,1 7{alpha}-diol. 5{alpha}- and 5β-androstane-3{alpha},1 7{alpha}-diol and the corresponding 17β-isomers, present similar patterns of increase throughout pubertal development, from stage 1 up to stage 5. Excretion levels are significantly different in general between stages 1, 2, 3 and 4, the highest percentage increase being observed between stages 3 and 4. None of the ratios of testosterone to epitestosterone glucuronides are beyond the threshold value of 6, where testosterone abuse by athletes is suspected. No particular pubertal stage exceeded this critical value with a probability higher than p=0.006, a value that was determined on the whole population. This is consistent with the non-significant differences between correlation slopes of regression curves, relating either testosterone or epitestosterone glucuronide to chronological age. The ratio of testosterone glucuronide to luteinizing hormone increases significantly throughout puberty and this might be a limitation to the widespread use of this ratio for the detection of testosterone misuse. Other ratios, such as testosterone glucuronide to epitestosterone (glucuronide + sulfate), glucuronides of testosterone to 5-androstene-3β,1 7{alpha}-diol, glucuronides of epitestosterone to 5-androstene-3β,1 7{alpha}-diol and epitestosterone glucuronide to sulfate, which have been suggested as efficient complementary criteria for the detection of testosterone and/or epitestosterone self-administration, have non-significant interstage variability, except between stages 3 and 4.

L Dehennin, Fondation de Recherche en Hormonologie, 67 Boulevard Pasteur, 94260 Fresnes, France







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.